C1 Inhibitor produced in the milk of transgenic non-human mammals
US7067713B2 · kind B2 · utility
15Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2001 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Feb 10, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides transgenic nonhuman mammals expressing C1 inhibitor in their milk. The C1 inhibitor is useful in treating patients with hereditary angioedema or patients requiring immunosuppression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.